VCP mutations in familial and sporadic amyotrophic lateral sclerosis

Max Koppers1, Marka M van Blitterswijk, Lotte Vlam

  • 1Department of Neurology, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, Utrecht, The Netherlands.

Neurobiology of Aging
|November 15, 2011
PubMed

Insights

Valosin-containing protein (VCP) gene mutations are a rare cause of familial amyotrophic lateral sclerosis (ALS). This study found VCP mutations play a limited role in sporadic ALS and related disorders.

Area of Science:

  • Genetics
  • Neurology

Background:

  • Valosin-containing protein (VCP) gene mutations are linked to familial amyotrophic lateral sclerosis (ALS), inclusion body myopathy (IBM), Paget's disease of bone (PDB), and frontotemporal dementia (FTD).
  • The frequency of VCP mutations in sporadic ALS, sporadic ALS-FTD, and progressive muscular atrophy (PMA) remains unknown.

Purpose of the Study:

  • To investigate the prevalence and spectrum of VCP gene mutations in patients with familial ALS, sporadic ALS, sporadic ALS-FTD, and PMA.

Main Methods:

  • Genetic screening of VCP gene mutations in a cohort of 93 familial ALS, 754 sporadic ALS, 58 sporadic ALS-FTD, and 264 PMA patients.
  • Utilized conservation analysis and protein prediction software to assess mutation pathogenicity.

Main Results:

  • Identified two nonsynonymous VCP mutations: a known mutation (p.R159H) in a familial ALS patient with a family history of FTD, and a novel mutation (p.I114V) in a sporadic ALS patient.
  • The p.I114V mutation was predicted to be a rare benign polymorphism.

Conclusions:

  • VCP mutations are an infrequent cause of familial ALS.
  • The contribution of VCP mutations to sporadic ALS and related conditions appears minimal.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...